Navigating the Choice of NOACs for Stroke Prevention in AF

Navigating the Choice of NOACs for Stroke Prevention in AF

A badge with ribbon in color black Cat3A(OnlineEdu)/1hr | An analog clock in color black 1 Hour | A black calendar with white triangle in center that has a black exclamation point in the middle 05 Aug 2022 

Overview

About this course

Stroke prevention is one of the cornerstones in the management of patients with atrial fibrillation (AF). AF increases stroke risk and is prevented using vitamin K antagonists or non-vitamin K antagonist oral anticoagulants (NOACs). The use of NOACs has led to improved clinical outcomes in AF patients in terms of stroke prevention. This e-learning module summarizes the data on the efficacy and safety of NOACs, their guidelines-based indications, and the reversal agents for NOAC-induced bleeding.


Learning outcomes

Upon completion of the educational activity, health care providers should be able to:
  • Identify potential NOACs for specific patients
  • Identify reversal agents for NOAC-induced bleeding

Topics covered

  • Stroke risk stratification
  • Vitamin K antagonists versus NOACs
  • The four approved NOACs
  • NOACs in the guidelines
  • Specific, non-specific, and emerging reversal agents
  • Patient specific indications for using each NOAC
  • Acceptability, accessibility, and affordability of NOACs

1 CME Point Available

A certificate can be downloaded upon successful completion of the quiz. Please use the information on the certificate to claim your CME points.